Table 1 Patient's characteristics (n=26)

From: Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

 

No.

%

Total

26

 

Sex

  

 Male

15

57.7

 Female

11

42.3

Age (years)

  

 Median

61.5

 

 Range

45–76

 

Histology

  

 Adeno

6

23

 Squamous

14

54

 Large

3

12

 Other

3

12

Performance status (ECOG)

 0

0

0

 1

19

73.1

 2

7

26.9

Disease stage

 IIIA

2

7.7

 IIIB

15

57.7

 IV

9

34.6

  1. ECOG=Eastern Oncology Cooperative Group.
Back to article page